AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 51 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.06 and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $291,000,000 | – | 493,597 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
| New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
| RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
| NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
| Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
| 683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
| Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
| EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
| Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |